Dasanat 50 mg Tablet
  1. Home
  2. Pharma Products
  3. Natco Pharma Ltd
  4. Dasanat 50 mg Tablet

Dasanat 50 mg Tablet

Dasanat 50 mg Tablet contains dasatinib 50 mg, a targeted anticancer medicine belonging to the tyrosine kinase inhibitor group. It is used mainly in the treatment of chronic myeloid leukemia and certain Philadelphia chromosome-positive acute lymphoblastic leukemia cases. The tablet is taken orally as prescribed by a qualified healthcare professional.

BUY NOW

Category

Dasatinib works by blocking abnormal tyrosine kinase proteins that signal cancer cells to grow and multiply. It can be used when certain leukemia treatments have not worked adequately or cannot be tolerated. Regular monitoring may include blood counts and assessment for fluid retention, bleeding, infections, and other treatment-related effects. The dose and duration are determined by the treating specialist according to the specific leukemia and treatment response.

Technical Specification

Specification Details
Active Ingredient Dasatinib
Strength 50 mg
Dosage Form Tablet
Route of Administration Oral
Pack Size 60 Tablets
Marketer Natco Pharma Ltd

Product Also Known As

Dasanat 50 mg Tablet, Dasanat 50mg Tablet, Dasanat 50 Tablet, Dasatinib 50 mg Tablet, Dasatinib 50mg Tablet, Dasatinib Oral Tablet, Dasatinib Anticancer Tablet